Abstract Etoposide is routinely used in combinationbased chemotherapy for testicular cancer and small-cell lung cancer; however, myelosuppression, therapy-related leukemia and neurotoxicity limit its utility. To determine the genetic contribution to cellular sensitivity to etoposide, we evaluated cell growth inhibition in Centre d' Etude du Polymorphisme Humain lymphoblastoid cell lines from 24 multi-generational pedigrees (321 samples) following treatment with 0.02-2.5 M etoposide for 72 h. Heritability analysis showed that genetic variation contributes signiWcantly to the cytotoxic phenotypes (h 2 = 0.17-0.25, P = 4.9 £ 10 ¡5 -7.3 £ 10 ¡3
Introduction
Etoposide is one of the most widely used chemotherapeutic agents for the treatment of germ cell tumors, small-cell lung cancer, leukemia and lymphomas (Baldwin and OsheroV 2005; Kopp et al. 2006; Rigas and Lara 2005) .
Although its eYcacy has been demonstrated as a single agent and in combination regimens, much of its anti-cancer beneWts are limited by toxicities including myelosuppression, neurotoxicity and therapy related leukemia (Baldwin and OsheroV 2005) .
The mechanism by which etoposide exerts its cytotoxic eVect is via targeting topoisomerase II, speciWcally by both stabilizing and increasing the concentration of the topoisomerase II-DNA cleavage complex (Ross et al. 1984; Yang et al. 1985) . While normally a short-lived intermediate within the catalytic cycle, an increased concentration of this complex within the cell leads to mutagenic eVects or cell death, primarily by means of the apoptotic pathways (Lowe et al. 1993 ). Although it is well known that etoposide acts by interacting with topoisomerase II, the cellular processes and genetic variation associated with sensitivity to etoposide still remain largely unknown.
In previous studies, our lab (Dolan et al. 2004 ) and others (Watters et al. 2004) have used large CEPH pedigrees to demonstrate that drug-induced cytotoxicity is heritable and associated with one or more genomic loci using linkage analysis. Within the large CEPH pedigrees are International European (CEU) HapMap trios that have publicly available enriched genotypic information. Our lab utilized a linkagedirected association analysis to narrow down the chromosomal regions to a speciWc list of SNPs associated with daunorubicin induced cytotoxicity (Duan et al. 2007) . In this report, lymphoblastoid cell lines (LCLs) derived from large CEPH pedigrees were used to identify the extent to which heritable factors contribute to etoposide-induced cytotoxicity. Whole genome linkage analysis was then followed by a linkage-directed association analysis to determine the extent to which SNPs within our linkage region contributed to the cytotoxic outcome.
Results

Cell cytotoxicity
Using a short-term cell growth inhibition assay, we determined the cytotoxic eVect of etoposide on 321 CEPH LCLs derived from 24 three-generation CEPH/Utah pedigrees. The median of the etoposide concentration required to inhibit 50% cellular growth (IC 50 ) for all 321 cell lines following treatment with etoposide for 72 h was 0.4 M. This value was in the lower range of those determined for a panel of NCI-60 human tumor cell lines (http:// dtp.nci.nih.gov/) treated with etoposide for a longer time period, 96 h (range 0.2-63 M, median 6.6 M). As shown in Fig. 1 , large variation in % survival for each concentration was observed. None of the Wve phenotypes (% cell survival at 0.02-2.5 M etoposide and IC 50 ) were normally distributed (P · 0.05) based on Kolmogorov-Smirnov statistic. Therefore, phenotype data were transformed using the inverse normalization of the percentile rank function in Microsoft Excel™ software for further analysis. To quantify the proportion of genetic factors contributing to human LCL variation in sensitivity to etoposide, heritability analysis was performed. The variation of the cytotoxic phenotypes among the 24 CEPH families is illustrated in Fig. 2 , with greater variation among families than within families. Sequential Oligogenic Linkage Analysis Routines (SOLAR) was used to calculate the heritability. As shown in Fig. 2 , the heritability values for each concentration and IC 50 range from 0.17 to 0.25, suggesting a signiWcant genetic component contributing to the cytotoxic eVect of etoposide. Age, sex and sex £ age were tested as covariates, but none were signiWcant.
Linkage analysis
Non-parametric linkage analysis was performed on Wve phenotypes (0.02, 0.1, 0.5, 2.5 M and IC 50 ) using 7,209 heterozygous SNPs and microsatellite markers. Drug cytotoxicity is likely a multigenic trait, therefore LOD¸1.5 was chosen in attempts to be inclusive of genes which have a moderate eVect on drug-induced cytotoxicity. Using MERLIN multipoint analyses, eight genomic regions displayed suggestive LOD scores of ¸1.5 on Wve chromosomes ( Fig. 3a ; Table 1 ). The highest LOD score (2.55) was seen following 0.02 M etoposide treatment and located on chromosome 5. Peaks on two chromosomal regions (chromosome 5 and 16) showed an inverse relationship between LOD score and concentration of drug tested indicative of genetic variants contributing to a greater extent at lower concentrations of etoposide in these regions (data not shown).
Association analysis
Association tests were performed between 103,168 common SNPs (minor allele frequency >5%) that were within the one LOD conWdence intervals for the signiWcant linkage peaks (LOD¸1.5) of all Wve chromosomes and the corresponding cytotoxic phenotype(s) at which a signiWcant linkage signal was detected. Another words, association studies were performed using the same phenotype (% survival following treatment with a given etoposide concentration) as the phenotype of the signiWcant linkage region. Figure 3b , c display SNPs found signiWcant within our identiWed linkage region on chromosome 4 and 11. We identiWed 22 unique SNPs signiWcantly associated with cytotoxic phenotypes, of which 13 SNPs associated with percentage survival following 0.02 M etoposide treatment, 3 SNPs with that of 0.5 M treatment and 6 SNPs with the IC 50 phenotype (Table 2) . Sixteen of 22 SNPs were located within 4 known gene regions, the remaining 6 SNPs resided within intergenic regions of the genome (P · 1 £ 10 ¡4 , false discovery rate (FDR) = 0.17 » 0.60). Four genes with signiWcant associated SNPs were found distributed among chromosomes 5, 11 and 16. No signiWcant associations were found between genetic markers in the linkage peak of chromosome 6 associated with survival at 0.5 M etoposide. 
Discussion
IdentiWcation of genetic variants that predict drug response is an important component of personalized medicine (Hartford and Dolan 2007; Katoh and Katoh 2004; Ooyama et al. 2007 ). In the current study, our objective was to ascertain the component of etoposide-induced cytotoxicity due to genetics with the long-term goal of identifying genetic variation that identiWes patients at risk for toxicity. Etoposideinduced cytotoxicity was determined to be a heritable trait with genetics contributing to 17-25% of the variation. Because the cell lines were derived from individuals within large pedigrees, whole genome linkage analysis was utilized to identify regions that harbored genetic variation important in sensitivity to etoposide. This list was further narrowed down by performing association studies with SNPs within the linkage regions (LOD¸1.5) on a subset of densely genotyped HapMap samples (n = 86) and the cytotoxic phenotype(s) for which a QTL signal was detected. The Wnal list of 22 SNPs identiWed through this linkage-directed association study are all considered important and may play a role in chemosensitivity through eVects on gene expression, function or protein stability.
With enriched resources of markers and SNP genotypic information (http://www.cephb.fr/cephdb/ and http:// www.hapmap.org) available, the LCL system has been used in mapping of genetic variants inXuencing other complex traits. Previously, cell response to ionizing radiation induced stress (Jen and Cheung 2003) , cytotoxicity (Dolan et al. 2004; Watters et al. 2004 ) and variation in mRNA expression level (Morley et al. 2004 ). Studies performed on cisplatin (Dolan et al. 2004) , 5-FU and docetaxel (Watters et al. 2004 ) and daunorubicin (Duan et al. 2007 ) have demonstrated that drug-induced cytotoxicity is heritable and amenable to genetic dissection. We compared the linkage peaks with those in our previous studies of daunorubicin (Duan et al. 2007 ) and cisplatin (Shukla et al. 2008) . Interestingly, the results show there are two peaks that overlap with other drug phenotypes (LOD¸1.5). The Wrst located at chromosome 4 (132-175 cM) for etoposide (IC 50 ) overlaps Although the same 24 large CEPH pedigrees were evaluated for daunorubicin, an additional 10 pedigrees were evaluated for cisplatin. Etoposide is known as an inhibitor of the enzyme topoisomerase II that controls and alters the topologic states of DNA during transcription (Ross et al. 1984; Yang et al. 1985) . In the present linkage and association studies, we failed to Wnd signiWcant association results for the topoisomerase II and other transporter genes that are involved in drug sensitivity. It is noteworthy that a candidate gene, GSTP1 is found in the chromosome 11 linkage peak (59-91 cM) with etoposide, although none of the SNPs in the GSTP1 locus shows signiWcant association with etoposide (data not shown). Our linkage-directed association analysis resulted in the identiWcation of 4 genes (SEMA5A, SLC7A6, PRMT7 and UVRAG) among three chromosomes (5, 11 and 16) harboring SNPs signiWcantly associated with sensitivity to etoposide.
As shown in Table 2 , a total of 12 high linkage disequilibrium SNPs in the intronic region of SEMA5A gene are shown to be associated with survival after treatment with 0.02 M etoposide. SEMA5A is a member of the semaphorin protein family which is involved in axonal guidance during neural development (Adams et al. 1996) . Previously, we also found two axon guidance pathway genes (NGEF and SLIT3) associated with daunorubicin induced cytotoxicity. We correlated the signiWcant SNPs with the gene expression level as described previously (Huang et al. 2007a ) and found that the SNPs (best SNP: rs369459, P = 3 £ 10 ¡7 ) in the SEMA5A gene loci were distantly associated with the expression of AMOT gene. AMOT is a member of angiostatin binding proteins that inhibit endogenous angiogenesis in vivo (Aase et al. 2007 ). In addition, two SLC7A6 SNPs and one PRMT7 SNP were found signiWcantly associated with cell survival at 0.5 M etoposide. SLC7A6 encodes an amino acid transporter. Expression level of SLC7A6 protein is involved in nitric oxide synthesis (Arancibia-Garavilla et al. 2003 ) that ultimately induces apoptosis and a series of other important biological (Leon et al. 2008) . PRMT7 is an arginine methyltransferase catalyzing an irreversible protein modiWcation (Miranda et al. 2004) . PRMT family members were found to be involved in a variety of processes (Bedford and Richard 2005) . Down-regulation of PRMT7 enzyme sensitizes tumor cells to camptothecin (Verbiest et al. 2008 ) and DNA damaging agents (Gros et al. 2006) . Our data supports the role of PRMT7 in cellular sensitivity to etoposide. A polymorphic site (rs7116263, C/G) was found within the intronic region of the gene UVRAG. This gene is implicated in resistance to damage induced by ultraviolet radiation as well as a positive regulator of Beclin-1 mediated autophagy (Liang et al. 2007 (Liang et al. , 1999 . By forming a complex with the phosphatidylinositol 3-kinase C3 (PI3KC3), Beclin-1 initiates the early stage production of autophagosomes. DiVerential interaction of Beclin-1 with BCL-2 in both normal and autophagic conditions shows suppression of autophagic activity (Pattingre et al. 2005) . Liang et al. (2006) performed detailed binding studies demonstrating that UVRAG and Beclin-1 directly interact and that Beclin-1 functions as a platform for the formation of the Bcl-2-UVRAG-PI3KC3 complex. A reduced level of Beclin-1 results in less UVRAG-induced autophagosome formation and vice versa (Liang et al. 2006) . Interestingly, recent evidence has implicated autophagy through Beclin-1 in CaSki cervical carcinoma cells treated with etoposide (Lee et al. 2007 ). Our whole genome approach identiWes a SNP within UVRAG associated with etoposide cytotoxicity. Further research on the role of this gene in sensitivity to etoposide is warranted.
Publicly available gene expression and genotypic data makes LCLs a potential resource to build models for identifying how genetic variation aVects susceptibility to drugs. Nonetheless, there are limitations with these cell lines. One limitation is the association studies in these cells is dependent on the SNPs identiWed through HapMap, thus they may not be the causal SNP but a marker in linkage disequilibrium. As more genetic markers are deposited, the linkage-directed association studies can be re-evaluated. In addition, the large CEPH pedigrees are derived from healthy Caucasian individuals of European descendants; hence results may not apply to individuals of diVerent ethnicities or even populations that experience severe chemotherapeutic toxicity. LCLs may not represent a phenotypic eVect that occurs in a speciWc tissue (e.g., neurotoxicity). Finally, although EBV transformation could introduce phenotypic or gene expression changes, the ability to map the expression phenotype (Cheung et al. 2005; Morley et al. 2004 ) provides some level of conWdence in the model for genetic studies because gene expression is genetically controlled. Despite these limitations, LCLs provide a comprehensive, unbiased model to discover pharmacogenomic signatures of chemotherapeutic agents that are not possible in humans.
Using a linkage-directed association approach with drug induced cytotoxicity allowed for the identiWcation of genes and SNPs contributing to human variation in sensitivity to etoposide. These Wndings may serve as a platform to further explore and improve our understanding of mechanisms of etoposide induced cytotoxicity and provides a list of potential genetic markers that may be further evaluated in clinical studies.
Materials and methods
Cell lines
Lymphoblastoid cell lines derived from 24 Caucasian Utah CEPH families (1331, 1333, 1334, 1340, 1341, 1344, 1345, 1346, 1347, 1349, 1350, 1358, 1362, 1375, 1408, 1413, 1416, 1420, 1423, 1444, 1447, 1454, 1459 and 1463) were purchased from the Coriell Institute for Medical Research (Camden, NJ). Cell lines were maintained in RPMI 1640 media (Mediatech, Herndon, VA) supplemented with 15% fetal bovine serum (HyClone, Logan, UT) and 1% L-glutamine (Invitrogen, Carlsbad, CA). Cell lines were diluted 3 times per week to a concentration 350,000 cells/ml and maintained at a 37°C, 5% CO 2 and 95% humidity.
Drug
Etoposide (NSC-141540) was kindly provided by the Drug Synthesis and Chemistry Branch, Division of Cancer Treatment, National Cancer Institute, Bethesda, MD.
Cell cytotoxicity assay
Cell growth inhibition was evaluated following increasing concentrations of etoposide treatment (0, 0.02, 0.1, 0.5 and 2.5 M for 72 h). Etoposide was prepared in 0.05% DMSO/ phosphate buVered saline immediately before use as described previously (Huang et al. 2007b ). Cell growth inhibition was determined using the non-toxic colorimetric based assay, alamarBlue ® (Biosource, Camarillo, CA) as described (Duan et al. 2007 Power was estimated to be the proportion of replicates in which the heritability was signiWcantly diVerent from 0 (P < 0.05). We had 83% power to detect a heritability of at least 0.15 in this analysis. Heritability analysis was performed using SOLAR to estimate narrow sense heritability (h 2 ) and test its signiWcance at each treatment concentration as described previously (Duan et al. 2007) . BrieXy, all phenotype data were transformed using the inverse normalization of the percentile rank function in Microsoft Excel™ software. Age, sex, and age £ sex interaction were used as covariates. Non-parametric linkage analysis was performed using MERLIN (Abecasis et al. 2002) as described previously (Duan et al. 2007 ). The genotypic data and map distances were downloaded from the CEPH Version 9 database and the MarshWeld map database using error-checked markers.
Error checking
Error checking for Mendelian incompatibility, misspeciWed relationships and unlikely recombinations have been performed as described previously (Dolan et al. 2004 ), however, this study utilized a much denser map. The web-based platform integrates and formats data (pedigree, genotype, phenotype), executes error checking using PedCheck (O'Connell and Weeks 1998) to detect genotypic incompatibilities, PREST (Sun et al. 2002) to detect relationship misspeciWcations and multipoint engine for rapid likelihood inference (MERLIN) (Abecasis et al. 2002) to detect unlikely recombinants prior to linkage analysis and is enabled to run linkage analysis on multiple platforms including MERLIN, GENEHUNTER and SOLAR. From the combined pool of genotyped markers, 7,209 SNP and microsatellite non-redundant markers yielding a very dense genetic map with highly heterozygous markers (heterozygosity: 1% at <0.7, 7% at 0.7-0.8, 28% at 0.8-0.9, 64% at 0.9-1) were utilized for linkage mapping studies.
SNPs associated with etoposide-induced cytotoxicity
The 90 HapMap CEU cell lines were a component of the 24 large pedigrees we evaluated for cytotoxicity. Four samples (GM11839, GM12716, GM12717 and GM12236) were not included in the analysis due to the low viability or unavailability from Coriell at the time of phenotyping. As shown in Table 1 , a total of 103,168 SNPs within the 1 LOD conWdence intervals of linkage regions with LOD scores ¸1.5 were retrieved from the HapMap database (release 22). Only the SNPs without Mendelian transmission errors and minor allele frequency ¸5% were included in the follow-up association analysis. Association between SNPs and percentile rank transformed phenotypes (the cytotoxic phenotype(s) for which a QTL signal was detected) was performed using the QTDT program (Abecasis et al. 2000a, b) . Gender was used as a covariate. P · 0.0001 was considered statistically signiWcant. FDR was used to control for multiple testing within each cytotoxic phenotype using the q value package in R statistics software (Storey and Tibshirani 2003) .
